Research for the Efficacy and Safety of Percutaneous Tibial Nerve Stimulation to Promote Storage Symptoms Postoperative Recovery for Patients With Benign Prostatic Hyperplasia

NANot yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

January 1, 2027

Conditions
Benign Prostatic HyperplasiaLower Urinary Tract Symptoms
Interventions
DEVICE

Percutaneous tibial nerve stimulation device

T-PTNS primarily delivers electrical stimulation to the sacral voiding center via the tibial nerve through the S2-S4 sacral plexus via skin-surface electrodes to improve patients' symptoms of urinary frequency, urgency, and urge incontinence.

DEVICE

Sham group device

The device in the sham group is manufactured by the same company and has the same appearance, display interface, and operation method as the device in the treatment group. These devices have the output circuit disconnected and no actual current output.

All Listed Sponsors
lead

Zhu Yiping

OTHER

NCT06742489 - Research for the Efficacy and Safety of Percutaneous Tibial Nerve Stimulation to Promote Storage Symptoms Postoperative Recovery for Patients With Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter